The targeting construct is designed to remove a 30-nucleotide telokin promoter sequence containing the AT-rich region and the CArG box of the gene by insertion of a loxP-flanked neomycin cassette. (J:341375)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count